BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7050501)

  • 1. Influence of cause-of-death assignment on time-to-tumor analyses in animal carcinogenesis studies.
    Kodell RL; Farmer JH; Gaylor DW; Cameron AM
    J Natl Cancer Inst; 1982 Sep; 69(3):659-64. PubMed ID: 7050501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of distributions of time to appearance of tumor and time to death from tumor after appearance in mice fed 2-acetylaminofluorene.
    Kodell RL; Farmer JH; Greenman DL; Frith CH
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):89-102. PubMed ID: 7365388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of tumors among litters of BALB/c female mice.
    Gaylor DW; Chen JJ; Greenman DL; Thompson CH
    J Natl Cancer Inst; 1985 Apr; 74(4):803-9. PubMed ID: 3857379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cage shelf level and spontaneous and induced neoplasms in mice.
    Greenman DL; Kodell RL; Sheldon WG
    J Natl Cancer Inst; 1984 Jul; 73(1):107-13. PubMed ID: 6376903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously.
    Farmer JH; Kodell RL; Greenman DL; Shaw GW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):55-68. PubMed ID: 7365386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-examination of the ED01 study--risk assessment using time.
    Fundam Appl Toxicol; 1981; 1(1):88-123. PubMed ID: 7184778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An illness-death model for the study of the carcinogenic process using survival/sacrifice data.
    Kodell RL; Nelson CJ
    Biometrics; 1980 Jun; 36(2):267-77. PubMed ID: 7407315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ED01 study: summary and conclusions.
    Gaylor DW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):179-83. PubMed ID: 7365380
    [No Abstract]   [Full Text] [Related]  

  • 9. A Weibull model for the estimation of tumorigenic potency.
    Dewanji A; Krewski D; Goddard MJ
    Biometrics; 1993 Jun; 49(2):367-77. PubMed ID: 8369373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-examination of the ED01 study. Overview.
    Fundam Appl Toxicol; 1981; 1(1):28-63. PubMed ID: 7184773
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of life-shortening effects in female BALB/C mice fed 2-acetylaminofluorene.
    Kodell RL; Farmer JH; Littlefield NA; Frith CH
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):69-87. PubMed ID: 7365387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-examination of the ED01 study - adjusting for time on study.
    Fundam Appl Toxicol; 1981; 1(1):67-80. PubMed ID: 7184775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of animal carcinogenicity experiments with multiple tumor types.
    Lu Y; Malani HM
    Biometrics; 1995 Mar; 51(1):73-86. PubMed ID: 7766797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of agreement among findings of pathologists in ED01 experiment.
    Amato DA; Lagakos SW
    J Natl Cancer Inst; 1988 Aug; 80(12):919-25. PubMed ID: 3398066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of total dose and dose rate in carcinogenicity studies.
    Littlefield NA; Gaylor DW
    J Toxicol Environ Health; 1985; 15(5):545-50. PubMed ID: 4046064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of a "clear and consistent threshold" for bladder and liver cancer in the large ED01 carcinogenicity study.
    Crump KS; Clewell HJ
    Toxicol Sci; 2003 Aug; 74(2):485; author reply 485-6. PubMed ID: 12730607
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimation of lag time between onset of and death from an occult tumor.
    Ahn H; Moon H; Kodell RL
    J Biopharm Stat; 2008; 18(5):901-14. PubMed ID: 18781524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonparametric joint estimators for disease resistance and survival functions in survival/sacrifice experiments.
    Kodell RL; Shaw GW; Johnson AM
    Biometrics; 1982 Mar; 38(1):43-58. PubMed ID: 7082762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating constraints that allow survival-adjusted incidence analyses in single-sacrifice studies.
    Dinse GE
    Biometrics; 1993 Jun; 49(2):399-407. PubMed ID: 8369376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of tumor response in rat liver by carbon tetrachloride.
    Taylor HW; Lijinsky W; Nettesheim P; Snyder CM
    Cancer Res; 1974 Dec; 34(12):3391-5. PubMed ID: 4371959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.